ProfileGDS4718 / 1565641_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 70% 72% 71% 75% 75% 69% 71% 73% 77% 73% 70% 73% 75% 69% 70% 71% 71% 73% 72% 82% 74% 71% 69% 70% 72% 69% 74% 71% 70% 77% 73% 69% 75% 71% 72% 72% 74% 73% 73% 68% 72% 72% 72% 70% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.9053470
GSM549102patient 115, normal, homogenized [OPG study]7.0095672
GSM549104patient 119, normal, homogenized [OPG study]7.044671
GSM549108patient 138, normal, homogenized [OPG study]7.2910875
GSM549119patient 077, normal, homogenized [OPG study]7.2820375
GSM549133patient 032, cancer, homogenized [OPG study]6.8445169
GSM549139patient 042, cancer, homogenized [OPG study]6.9852671
GSM549099patient 107, normal, homogenized [OPG study]7.0910373
GSM549109patient 139, normal, homogenized [OPG study]7.4643677
GSM549110patient 046, normal, homogenized [OPG study]7.0811773
GSM549114patient 063, normal, homogenized [OPG study]6.8585170
GSM549122patient 082, normal, homogenized [OPG study]7.1458973
GSM549134patient 033, cancer, homogenized [OPG study]7.3027775
GSM549136patient 036, cancer, homogenized [OPG study]6.866769
GSM549140patient 044, cancer, homogenized [OPG study]6.9320770
GSM549111patient 047, normal, homogenized [OPG study]7.0230171
GSM549113patient 057, normal, homogenized [OPG study]6.9843371
GSM549132patient 031, cancer, homogenized [OPG study]7.1496973
GSM549137patient 038, cancer, homogenized [OPG study]7.1003372
GSM549142patient 047, cancer, homogenized [OPG study]7.7997882
GSM549100patient 110, normal, homogenized [OPG study]7.1280474
GSM549107patient 135, normal, homogenized [OPG study]6.962271
GSM549115patient 068, normal, homogenized [OPG study]6.8006969
GSM549116patient 072, normal, homogenized [OPG study]6.9225570
GSM549120patient 078, normal, homogenized [OPG study]7.008772
GSM549131patient 030, cancer, homogenized [OPG study]6.8655769
GSM549118patient 074, normal, homogenized [OPG study]7.2350174
GSM549129patient 027, cancer, homogenized [OPG study]7.0440571
GSM549123patient 088, normal, homogenized [OPG study]6.8778170
GSM549124patient 006, cancer, homogenized [OPG study]7.481277
GSM549126patient 015, cancer, homogenized [OPG study]7.1128173
GSM549128patient 025, cancer, homogenized [OPG study]6.8832669
GSM549103patient 117, normal, homogenized [OPG study]7.2095275
GSM549117patient 073, normal, homogenized [OPG study]6.8855271
GSM549138patient 041, cancer, homogenized [OPG study]7.0926272
GSM549141patient 045, cancer, homogenized [OPG study]7.1865172
GSM549130patient 028, cancer, homogenized [OPG study]7.2107574
GSM549101patient 111, normal, homogenized [OPG study]7.1286573
GSM549105patient 128, normal, homogenized [OPG study]7.1061973
GSM549106patient 134, normal, homogenized [OPG study]6.7395568
GSM549112patient 048, normal, homogenized [OPG study]7.0519772
GSM549125patient 011, cancer, homogenized [OPG study]7.0137472
GSM549127patient 024, cancer, homogenized [OPG study]7.1527972
GSM549135patient 035, cancer, homogenized [OPG study]6.9204570